Filing Details
- Accession Number:
- 0001104659-19-032920
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-30 21:27:55
- Reporting Period:
- 2019-05-28
- Accepted Time:
- 2019-05-30 21:27:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1761612 | Bicycle Therapeutics Plc | BCYC | Pharmaceutical Preparations (2834) | V8 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1114448 | Ag Novartis | Lichtstrasse 35 Basel V8 CH 4056 | No | No | Yes | No | |
| 1297709 | Ltd Bioventures Novartis | C/O Novartis International Ag Wsj-200.220 Ch-4002 Basel V8 0000000000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-05-28 | 893,195 | $0.00 | 893,195 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2019-05-28 | 71,450 | $0.00 | 964,645 | No | 4 | X | Direct | |
| Ordinary Shares | Acquisiton | 2019-05-28 | 636,366 | $0.00 | 1,601,011 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2019-05-28 | 168,630 | $14.00 | 1,769,641 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | X | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Series A Preferred Shares | Disposition | 2019-05-28 | 893,195 | $0.00 | 893,195 | $0.00 |
| Ordinary Shares | Series A Preferred Shares Warrants | Disposition | 2019-05-28 | 71,450 | $0.00 | 71,450 | $0.00 |
| Ordinary Shares | Series B1 Preferred Shares | Disposition | 2019-05-28 | 636,366 | $0.00 | 636,366 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | X | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each Series A and B1 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.
Billionaire Hedge Funds
